NF1 and cancer: In our patient, saliva germline testing did not reveal mutations in NF1 or other cancer-predisposing genes; however, routine clinical testing possesses several limitations and may miss structural variants or mutations in genes not included on targeted panels, limiting its ability to fully rule out an underlying genetic driver [7].